A randomised placebo-controlled Phase III multicentre trial: low-dose intravenous immunoglobulin treatment for long-standing complex regional pain syndrome (LIPS trial).

Low-dose intravenous immunoglobulin was not effective in relieving pain in longstanding complex regional pain syndrome.

http://ift.tt/2zb5SAY